SINUVA™ Sinus Implant

SINUVA™ is a corticosteroid-eluting sinus implant for the treatment of chronic rhinosinusitis with nasal polyps in adults who have had ethmoid sinus surgery. Placed during a routine office visit, the self-expanding implant delivers mometasone furoate directly to the polyp tissue and is clinically proven to shrink nasal polyps and reduce nasal obstruction.

• 2-in-1 mechanism: self-expanding, bioabsorbable design that softens over time while delivering medication
• Targeted delivery of 1350 mcg of mometasone furoate over up to 90 days
• Placed in a physician's office in a routine visit — a non-surgical treatment option
• Clinically shown to shrink polyps, reduce obstruction and congestion, and improve sense of smell
• In clinical studies, fewer treated patients required repeat sinus surgery